Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms, Hereditary Nonpolyposis | 12 | 2023 | 378 | 0.990 |
Why?
|
Adenocarcinoma | 25 | 2022 | 6317 | 0.950 |
Why?
|
Microsatellite Repeats | 17 | 2005 | 787 | 0.920 |
Why?
|
DNA Mismatch Repair | 6 | 2022 | 428 | 0.840 |
Why?
|
Genes, APC | 11 | 2008 | 145 | 0.770 |
Why?
|
Barrett Esophagus | 3 | 2021 | 492 | 0.760 |
Why?
|
Appendiceal Neoplasms | 1 | 2023 | 155 | 0.750 |
Why?
|
Colorectal Neoplasms | 29 | 2022 | 6824 | 0.740 |
Why?
|
Colonic Neoplasms | 13 | 2016 | 2510 | 0.730 |
Why?
|
Esophageal Neoplasms | 6 | 2021 | 1645 | 0.620 |
Why?
|
Base Pair Mismatch | 10 | 2004 | 92 | 0.590 |
Why?
|
Endometrial Neoplasms | 4 | 2023 | 1367 | 0.560 |
Why?
|
Tumor Suppressor Protein p53 | 12 | 2021 | 2899 | 0.560 |
Why?
|
Pancreatic Neoplasms | 23 | 2009 | 5292 | 0.470 |
Why?
|
Jews | 6 | 2003 | 359 | 0.470 |
Why?
|
Keratins | 3 | 2021 | 497 | 0.470 |
Why?
|
Neoplasms, Glandular and Epithelial | 2 | 2012 | 487 | 0.450 |
Why?
|
Adenomatous Polyposis Coli | 6 | 2008 | 218 | 0.440 |
Why?
|
Microsatellite Instability | 6 | 2016 | 712 | 0.430 |
Why?
|
Cytoskeletal Proteins | 8 | 2005 | 1343 | 0.390 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 2 | 2009 | 83 | 0.380 |
Why?
|
Loss of Heterozygosity | 5 | 2011 | 660 | 0.330 |
Why?
|
Dacarbazine | 2 | 2009 | 560 | 0.320 |
Why?
|
Point Mutation | 4 | 1999 | 1595 | 0.310 |
Why?
|
Adenoma | 12 | 2015 | 2146 | 0.310 |
Why?
|
Genes, p53 | 9 | 2007 | 712 | 0.290 |
Why?
|
Precancerous Conditions | 5 | 2018 | 974 | 0.290 |
Why?
|
Neuroendocrine Tumors | 3 | 2009 | 645 | 0.280 |
Why?
|
Genes, ras | 8 | 2007 | 655 | 0.280 |
Why?
|
DNA, Neoplasm | 15 | 2007 | 1746 | 0.270 |
Why?
|
Gastritis | 2 | 2023 | 198 | 0.260 |
Why?
|
Germ-Line Mutation | 10 | 2009 | 1826 | 0.250 |
Why?
|
MutS Homolog 2 Protein | 15 | 2015 | 195 | 0.250 |
Why?
|
Neoplasm Proteins | 11 | 2008 | 3606 | 0.250 |
Why?
|
Cell Transformation, Neoplastic | 9 | 2010 | 2818 | 0.250 |
Why?
|
Colonic Polyps | 4 | 2022 | 547 | 0.250 |
Why?
|
DNA Repair | 13 | 2004 | 2022 | 0.240 |
Why?
|
Immunohistochemistry | 19 | 2021 | 11025 | 0.240 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2006 | 722 | 0.230 |
Why?
|
Helicobacter heilmannii | 1 | 2023 | 6 | 0.230 |
Why?
|
DNA-Binding Proteins | 14 | 2015 | 9561 | 0.230 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2012 | 950 | 0.230 |
Why?
|
Intestinal Neoplasms | 5 | 2008 | 311 | 0.230 |
Why?
|
Proto-Oncogene Proteins | 12 | 2005 | 4489 | 0.220 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2023 | 150 | 0.200 |
Why?
|
Colitis | 3 | 2023 | 1223 | 0.200 |
Why?
|
Cyclooxygenase 2 Inhibitors | 4 | 2009 | 320 | 0.200 |
Why?
|
Granuloma, Foreign-Body | 1 | 2021 | 43 | 0.190 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 7 | 2006 | 696 | 0.190 |
Why?
|
Trans-Activators | 5 | 2005 | 2855 | 0.180 |
Why?
|
Adenomatous Polyps | 3 | 2008 | 108 | 0.180 |
Why?
|
Helicobacter pylori | 1 | 2023 | 379 | 0.180 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2788 | 0.180 |
Why?
|
Helicobacter Infections | 1 | 2023 | 387 | 0.180 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2022 | 241 | 0.170 |
Why?
|
Genetic Techniques | 1 | 2003 | 428 | 0.170 |
Why?
|
Esophagectomy | 2 | 2021 | 468 | 0.160 |
Why?
|
Sulfonamides | 5 | 2009 | 1970 | 0.160 |
Why?
|
Aneuploidy | 2 | 2001 | 551 | 0.150 |
Why?
|
Pyrazoles | 5 | 2009 | 1983 | 0.150 |
Why?
|
Adenomyoma | 1 | 1997 | 8 | 0.150 |
Why?
|
beta Catenin | 7 | 2010 | 1043 | 0.150 |
Why?
|
Gene Deletion | 8 | 2006 | 2667 | 0.140 |
Why?
|
Common Bile Duct | 1 | 1997 | 109 | 0.140 |
Why?
|
Thymidylate Synthase | 1 | 2016 | 72 | 0.140 |
Why?
|
Gastrectomy | 1 | 2021 | 667 | 0.140 |
Why?
|
Mutation | 24 | 2018 | 29764 | 0.140 |
Why?
|
Polymorphism, Genetic | 4 | 2008 | 4284 | 0.140 |
Why?
|
Common Bile Duct Neoplasms | 1 | 1997 | 120 | 0.140 |
Why?
|
Cholecystitis | 1 | 1997 | 182 | 0.140 |
Why?
|
Aged, 80 and over | 24 | 2021 | 58608 | 0.130 |
Why?
|
Alleles | 8 | 2008 | 6886 | 0.130 |
Why?
|
Muir-Torre Syndrome | 1 | 2015 | 12 | 0.130 |
Why?
|
Bile Duct Diseases | 1 | 1996 | 98 | 0.130 |
Why?
|
Adenomatous Polyposis Coli Protein | 5 | 2006 | 180 | 0.130 |
Why?
|
Humans | 96 | 2023 | 756111 | 0.130 |
Why?
|
Tumor Suppressor Protein p14ARF | 2 | 2006 | 85 | 0.120 |
Why?
|
Polycystic Kidney Diseases | 1 | 1996 | 133 | 0.120 |
Why?
|
Female | 66 | 2023 | 388229 | 0.120 |
Why?
|
Lymph Nodes | 2 | 2006 | 3480 | 0.120 |
Why?
|
Pancreatic Diseases | 1 | 1997 | 344 | 0.120 |
Why?
|
Middle Aged | 51 | 2021 | 218357 | 0.120 |
Why?
|
Fluorouracil | 3 | 2016 | 1604 | 0.120 |
Why?
|
Prognosis | 12 | 2021 | 29463 | 0.120 |
Why?
|
DNA Polymerase I | 1 | 1994 | 43 | 0.120 |
Why?
|
Amino Acid Substitution | 1 | 1999 | 1736 | 0.120 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2009 | 617 | 0.120 |
Why?
|
Polymerase Chain Reaction | 9 | 2011 | 6067 | 0.120 |
Why?
|
Aged | 41 | 2021 | 167585 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 12 | 2015 | 2896 | 0.110 |
Why?
|
BRCA1 Protein | 3 | 2000 | 1134 | 0.110 |
Why?
|
Disease Progression | 8 | 2021 | 13432 | 0.110 |
Why?
|
Male | 59 | 2023 | 356852 | 0.110 |
Why?
|
Endosonography | 1 | 1997 | 605 | 0.110 |
Why?
|
Carcinoma in Situ | 3 | 2005 | 796 | 0.110 |
Why?
|
Vasculitis | 1 | 1997 | 522 | 0.110 |
Why?
|
Carcinoma | 4 | 2015 | 2344 | 0.100 |
Why?
|
DNA Mutational Analysis | 9 | 2008 | 4111 | 0.100 |
Why?
|
Adult | 42 | 2021 | 218302 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2009 | 1690 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 5 | 2021 | 3515 | 0.100 |
Why?
|
Enterocytes | 4 | 2007 | 221 | 0.100 |
Why?
|
DNA Repair Enzymes | 2 | 2015 | 344 | 0.100 |
Why?
|
Intestinal Mucosa | 8 | 2008 | 3003 | 0.100 |
Why?
|
Survival Analysis | 8 | 2009 | 10183 | 0.090 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2011 | 246 | 0.090 |
Why?
|
Conserved Sequence | 1 | 1994 | 1165 | 0.090 |
Why?
|
Colitis, Ulcerative | 2 | 2022 | 1917 | 0.090 |
Why?
|
Neoplasm Staging | 7 | 2016 | 11106 | 0.090 |
Why?
|
Cysts | 1 | 1996 | 685 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2803 | 0.090 |
Why?
|
Codon | 3 | 1999 | 602 | 0.090 |
Why?
|
Isoenzymes | 3 | 2004 | 1689 | 0.090 |
Why?
|
Mutation, Missense | 3 | 2008 | 2554 | 0.090 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2009 | 520 | 0.090 |
Why?
|
Bacitracin | 1 | 1989 | 24 | 0.090 |
Why?
|
rho GTP-Binding Proteins | 2 | 2008 | 279 | 0.090 |
Why?
|
Sequence Analysis, DNA | 4 | 2007 | 4703 | 0.080 |
Why?
|
Fibromatosis, Aggressive | 1 | 2010 | 124 | 0.080 |
Why?
|
Carrier Proteins | 11 | 2005 | 4939 | 0.080 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2010 | 2410 | 0.080 |
Why?
|
Proctocolectomy, Restorative | 2 | 2001 | 190 | 0.080 |
Why?
|
Captopril | 1 | 1989 | 264 | 0.080 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 3 | 2004 | 318 | 0.080 |
Why?
|
Nuclear Proteins | 11 | 2015 | 5787 | 0.080 |
Why?
|
Pilomatrixoma | 2 | 2005 | 24 | 0.080 |
Why?
|
HMGA1a Protein | 1 | 2008 | 63 | 0.080 |
Why?
|
Sebaceous Gland Neoplasms | 1 | 2008 | 40 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11607 | 0.080 |
Why?
|
Pancreatic Ducts | 2 | 2008 | 329 | 0.080 |
Why?
|
p21-Activated Kinases | 1 | 2008 | 128 | 0.080 |
Why?
|
Leucine | 1 | 1989 | 550 | 0.070 |
Why?
|
Cardia | 1 | 2007 | 59 | 0.070 |
Why?
|
Hair Diseases | 2 | 2005 | 72 | 0.070 |
Why?
|
Prevalence | 2 | 2022 | 15599 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2006 | 3772 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2016 | 8438 | 0.070 |
Why?
|
Liver Diseases | 1 | 1996 | 1283 | 0.070 |
Why?
|
Leucovorin | 1 | 2009 | 614 | 0.070 |
Why?
|
Carcinoid Tumor | 1 | 2009 | 229 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2010 | 727 | 0.070 |
Why?
|
Keratin-20 | 1 | 2006 | 31 | 0.070 |
Why?
|
Keratin-7 | 1 | 2006 | 55 | 0.070 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6806 | 0.070 |
Why?
|
Intestinal Polyps | 2 | 2008 | 104 | 0.070 |
Why?
|
Estrogen Receptor beta | 1 | 2007 | 169 | 0.070 |
Why?
|
Risk Assessment | 6 | 2021 | 23956 | 0.070 |
Why?
|
Heterozygote | 5 | 2003 | 2787 | 0.060 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2000 | 588 | 0.060 |
Why?
|
Esophagogastric Junction | 1 | 2007 | 338 | 0.060 |
Why?
|
Camptothecin | 1 | 2009 | 581 | 0.060 |
Why?
|
Actomyosin | 1 | 2006 | 109 | 0.060 |
Why?
|
Coumestrol | 1 | 2004 | 1 | 0.060 |
Why?
|
Liver Neoplasms | 3 | 2008 | 4296 | 0.060 |
Why?
|
Skin Neoplasms | 5 | 2009 | 5785 | 0.060 |
Why?
|
Phenanthrenes | 1 | 2005 | 67 | 0.060 |
Why?
|
Genistein | 1 | 2004 | 86 | 0.060 |
Why?
|
Fungal Proteins | 3 | 2005 | 908 | 0.060 |
Why?
|
Phytoestrogens | 1 | 2004 | 59 | 0.060 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2006 | 235 | 0.060 |
Why?
|
Carcinoembryonic Antigen | 1 | 2006 | 336 | 0.060 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 2008 | 364 | 0.060 |
Why?
|
Cadherins | 2 | 2006 | 897 | 0.060 |
Why?
|
Intestinal Polyposis | 1 | 2004 | 42 | 0.060 |
Why?
|
Mice | 22 | 2023 | 80709 | 0.060 |
Why?
|
DNA Glycosylases | 1 | 2004 | 124 | 0.060 |
Why?
|
Chromosomal Instability | 1 | 2004 | 177 | 0.060 |
Why?
|
Bloom Syndrome | 1 | 2003 | 10 | 0.060 |
Why?
|
Immunoenzyme Techniques | 3 | 2007 | 1709 | 0.060 |
Why?
|
Allelic Imbalance | 1 | 2004 | 77 | 0.060 |
Why?
|
Mice, Nude | 5 | 2008 | 3588 | 0.060 |
Why?
|
Carcinoma, Papillary | 1 | 2009 | 786 | 0.060 |
Why?
|
Mice, Inbred C57BL | 11 | 2023 | 21780 | 0.050 |
Why?
|
Pedigree | 9 | 2003 | 4565 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 1997 | 3514 | 0.050 |
Why?
|
Estrogen Receptor alpha | 1 | 2007 | 578 | 0.050 |
Why?
|
Breast Neoplasms | 7 | 2009 | 20889 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2023 | 18009 | 0.050 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2008 | 2052 | 0.050 |
Why?
|
Phosphorylation | 5 | 2010 | 8312 | 0.050 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2001 | 1086 | 0.050 |
Why?
|
Sigmoid Neoplasms | 2 | 2004 | 53 | 0.050 |
Why?
|
Animals | 25 | 2023 | 167069 | 0.050 |
Why?
|
Biopsy | 5 | 2018 | 6760 | 0.050 |
Why?
|
Gastrointestinal Transit | 1 | 2002 | 94 | 0.050 |
Why?
|
Genomic Instability | 1 | 2005 | 693 | 0.050 |
Why?
|
Transcription Factors | 2 | 2000 | 12069 | 0.050 |
Why?
|
Pouchitis | 1 | 2001 | 64 | 0.050 |
Why?
|
Lymphatic Metastasis | 2 | 2006 | 2937 | 0.050 |
Why?
|
Predictive Value of Tests | 5 | 2015 | 15228 | 0.050 |
Why?
|
New England | 1 | 2023 | 1038 | 0.050 |
Why?
|
Nausea | 1 | 2023 | 673 | 0.050 |
Why?
|
Gastroenterology | 1 | 2007 | 562 | 0.050 |
Why?
|
Glucagon | 1 | 2002 | 527 | 0.040 |
Why?
|
Genes, DCC | 1 | 1999 | 10 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 1 | 2006 | 1114 | 0.040 |
Why?
|
Carcinoma, Medullary | 1 | 2000 | 115 | 0.040 |
Why?
|
Ontario | 3 | 2008 | 400 | 0.040 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2003 | 638 | 0.040 |
Why?
|
Arrhythmias, Cardiac | 1 | 1989 | 2248 | 0.040 |
Why?
|
Molecular Sequence Data | 7 | 2000 | 17607 | 0.040 |
Why?
|
Carcinoma, Basal Cell | 1 | 2005 | 557 | 0.040 |
Why?
|
Base Sequence | 6 | 1996 | 12439 | 0.040 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 1999 | 59 | 0.040 |
Why?
|
Gastrointestinal Agents | 1 | 2004 | 507 | 0.040 |
Why?
|
Blood Proteins | 1 | 2004 | 1153 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 8 | 2004 | 17684 | 0.040 |
Why?
|
DNA, Satellite | 2 | 1996 | 67 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2008 | 2864 | 0.040 |
Why?
|
Hyperplasia | 4 | 2008 | 1155 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2864 | 0.040 |
Why?
|
Cell Adhesion Molecules | 1 | 2005 | 1600 | 0.040 |
Why?
|
Chromosomes, Human, Pair 17 | 2 | 2004 | 419 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 3 | 2007 | 1305 | 0.040 |
Why?
|
Proteome | 1 | 2008 | 1828 | 0.040 |
Why?
|
Gene Silencing | 1 | 2005 | 1514 | 0.040 |
Why?
|
Protein Precursors | 1 | 2002 | 1131 | 0.040 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2001 | 867 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2023 | 79746 | 0.040 |
Why?
|
Frozen Sections | 1 | 1998 | 154 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1646 | 0.040 |
Why?
|
Interleukin-10 | 1 | 2023 | 1163 | 0.040 |
Why?
|
Neoplasms | 2 | 2004 | 21899 | 0.040 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1998 | 385 | 0.040 |
Why?
|
Tumor Cells, Cultured | 4 | 2003 | 6143 | 0.040 |
Why?
|
Abdominal Pain | 1 | 2023 | 1063 | 0.040 |
Why?
|
Cyclins | 2 | 1998 | 594 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2005 | 2004 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2012 | 5186 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 1942 | 0.030 |
Why?
|
Exons | 2 | 2000 | 2385 | 0.030 |
Why?
|
Cyclooxygenase 2 | 3 | 2004 | 599 | 0.030 |
Why?
|
Cell Movement | 2 | 2008 | 5178 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2004 | 3472 | 0.030 |
Why?
|
Esophagoscopy | 1 | 2018 | 392 | 0.030 |
Why?
|
Tyrosine | 3 | 2005 | 1440 | 0.030 |
Why?
|
BRCA2 Protein | 2 | 2000 | 792 | 0.030 |
Why?
|
Genes, BRCA1 | 1 | 2000 | 767 | 0.030 |
Why?
|
Gene Expression Profiling | 3 | 2007 | 9341 | 0.030 |
Why?
|
Intestines | 1 | 2004 | 1902 | 0.030 |
Why?
|
Stomach Neoplasms | 1 | 2005 | 1409 | 0.030 |
Why?
|
src-Family Kinases | 2 | 2010 | 535 | 0.030 |
Why?
|
Genetic Markers | 4 | 2007 | 2607 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2021 | 64582 | 0.030 |
Why?
|
Vanadates | 2 | 2005 | 82 | 0.030 |
Why?
|
Europe | 2 | 2000 | 3415 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2023 | 4342 | 0.030 |
Why?
|
Intestine, Small | 3 | 2006 | 1202 | 0.030 |
Why?
|
Breast Diseases | 1 | 1998 | 443 | 0.030 |
Why?
|
Risk Factors | 9 | 2021 | 73898 | 0.030 |
Why?
|
Melanoma | 2 | 2006 | 5659 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2016 | 8558 | 0.030 |
Why?
|
Organ Specificity | 1 | 1999 | 1954 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2008 | 2447 | 0.030 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 1997 | 511 | 0.030 |
Why?
|
Genetic Diseases, Inborn | 1 | 1999 | 597 | 0.030 |
Why?
|
Cholestasis | 1 | 1997 | 375 | 0.030 |
Why?
|
Antineoplastic Agents | 3 | 2012 | 13578 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 2008 | 2880 | 0.030 |
Why?
|
Computational Biology | 2 | 2004 | 3486 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2004 | 2801 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2004 | 3594 | 0.030 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2001 | 936 | 0.030 |
Why?
|
Glioblastoma | 1 | 2008 | 3479 | 0.030 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2008 | 2414 | 0.030 |
Why?
|
Neoplasm Invasiveness | 3 | 2008 | 3608 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2023 | 3203 | 0.030 |
Why?
|
Child | 6 | 2023 | 79418 | 0.030 |
Why?
|
Dinoprostone | 2 | 2006 | 596 | 0.030 |
Why?
|
Radiographic Image Enhancement | 1 | 1997 | 880 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2009 | 10806 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2008 | 12755 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 9113 | 0.030 |
Why?
|
Immunoprecipitation | 2 | 2004 | 879 | 0.030 |
Why?
|
Kidney Diseases | 2 | 2006 | 2058 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2003 | 4874 | 0.020 |
Why?
|
Gene Targeting | 1 | 1995 | 838 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 1997 | 1633 | 0.020 |
Why?
|
Case-Control Studies | 4 | 2018 | 21917 | 0.020 |
Why?
|
Signal Transduction | 6 | 2008 | 23254 | 0.020 |
Why?
|
Phenotype | 6 | 2008 | 16442 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2002 | 20421 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 2 | 2004 | 311 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2006 | 2271 | 0.020 |
Why?
|
Diagnosis, Differential | 3 | 2007 | 12950 | 0.020 |
Why?
|
Adenosine Triphosphatases | 1 | 2015 | 833 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 1999 | 1960 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2004 | 4019 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2008 | 2849 | 0.020 |
Why?
|
Prospective Studies | 4 | 2009 | 54040 | 0.020 |
Why?
|
Brain Neoplasms | 2 | 2009 | 8917 | 0.020 |
Why?
|
Models, Genetic | 3 | 2007 | 3439 | 0.020 |
Why?
|
Homozygote | 2 | 2006 | 1783 | 0.020 |
Why?
|
Probability | 2 | 2007 | 2479 | 0.020 |
Why?
|
Cell Differentiation | 3 | 2007 | 11439 | 0.020 |
Why?
|
Peptides | 1 | 2002 | 4321 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2007 | 7439 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2002 | 5085 | 0.020 |
Why?
|
Acute Disease | 2 | 1997 | 7229 | 0.020 |
Why?
|
Aminopeptidases | 1 | 1989 | 95 | 0.020 |
Why?
|
DNA | 1 | 2003 | 7222 | 0.020 |
Why?
|
Proteins | 1 | 2004 | 6026 | 0.020 |
Why?
|
Cell Adhesion | 2 | 2006 | 3091 | 0.020 |
Why?
|
In Situ Hybridization | 2 | 2004 | 1897 | 0.020 |
Why?
|
Back | 1 | 2008 | 65 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2005 | 13425 | 0.020 |
Why?
|
Mice, Transgenic | 3 | 2007 | 9479 | 0.020 |
Why?
|
Mice, Mutant Strains | 2 | 2006 | 1763 | 0.020 |
Why?
|
Keratoacanthoma | 1 | 2008 | 33 | 0.020 |
Why?
|
Digoxin | 1 | 1989 | 247 | 0.020 |
Why?
|
Genotype | 3 | 2005 | 12876 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 694 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 320 | 0.020 |
Why?
|
Genome | 2 | 2007 | 1736 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2009 | 9262 | 0.020 |
Why?
|
Feces | 1 | 1994 | 1450 | 0.020 |
Why?
|
Guinea Pigs | 1 | 1989 | 1312 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2008 | 872 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2008 | 6244 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 1989 | 1383 | 0.020 |
Why?
|
Time Factors | 3 | 2021 | 39991 | 0.020 |
Why?
|
Mice, Knockout | 4 | 2006 | 14318 | 0.020 |
Why?
|
Metaplasia | 1 | 2007 | 320 | 0.020 |
Why?
|
Receptors, Prostaglandin | 1 | 2006 | 54 | 0.020 |
Why?
|
Lipoxygenase | 1 | 2006 | 72 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1995 | 1522 | 0.020 |
Why?
|
Tyrphostins | 1 | 2006 | 63 | 0.020 |
Why?
|
Actin Depolymerizing Factors | 1 | 2006 | 42 | 0.020 |
Why?
|
Egtazic Acid | 1 | 2006 | 169 | 0.020 |
Why?
|
Cell Line, Tumor | 3 | 2008 | 16782 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2006 | 43 | 0.020 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2006 | 87 | 0.020 |
Why?
|
Algorithms | 2 | 2008 | 13940 | 0.020 |
Why?
|
Up-Regulation | 2 | 2006 | 4116 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 2 | 1998 | 359 | 0.020 |
Why?
|
Myosin Light Chains | 1 | 2006 | 121 | 0.020 |
Why?
|
Survival Rate | 3 | 2008 | 12790 | 0.020 |
Why?
|
Colectomy | 2 | 2004 | 691 | 0.020 |
Why?
|
Pancreas, Exocrine | 1 | 2006 | 48 | 0.020 |
Why?
|
Chromosome Mapping | 3 | 2000 | 4627 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 371 | 0.020 |
Why?
|
Cardiovascular Diseases | 2 | 2009 | 15659 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 615 | 0.020 |
Why?
|
Rosmarinus | 1 | 2005 | 1 | 0.020 |
Why?
|
Cardiac Myosins | 1 | 2006 | 120 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2008 | 642 | 0.020 |
Why?
|
Muscle Relaxants, Central | 1 | 2006 | 91 | 0.020 |
Why?
|
Thorax | 1 | 2008 | 552 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2008 | 813 | 0.020 |
Why?
|
Rosaniline Dyes | 1 | 2004 | 48 | 0.020 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2004 | 69 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 478 | 0.010 |
Why?
|
Mucous Membrane | 1 | 2007 | 656 | 0.010 |
Why?
|
Ultrasonography | 1 | 1997 | 5938 | 0.010 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2006 | 699 | 0.010 |
Why?
|
Multivariate Analysis | 3 | 2004 | 12160 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2008 | 1829 | 0.010 |
Why?
|
Macrophages, Peritoneal | 1 | 2004 | 233 | 0.010 |
Why?
|
Placebos | 1 | 2008 | 1667 | 0.010 |
Why?
|
Sensitivity and Specificity | 3 | 2004 | 14654 | 0.010 |
Why?
|
False Negative Reactions | 1 | 2004 | 573 | 0.010 |
Why?
|
Lysophospholipids | 1 | 2006 | 339 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2011 | 12503 | 0.010 |
Why?
|
Sequence Deletion | 2 | 2000 | 1494 | 0.010 |
Why?
|
GPI-Linked Proteins | 1 | 2005 | 467 | 0.010 |
Why?
|
Amides | 1 | 2006 | 451 | 0.010 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2004 | 299 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2004 | 1142 | 0.010 |
Why?
|
Clathrin | 1 | 2004 | 261 | 0.010 |
Why?
|
Cyclin D1 | 1 | 2005 | 452 | 0.010 |
Why?
|
Jurkat Cells | 1 | 2004 | 729 | 0.010 |
Why?
|
Extremities | 1 | 2008 | 857 | 0.010 |
Why?
|
Proglucagon | 1 | 2002 | 32 | 0.010 |
Why?
|
Remission Induction | 1 | 2008 | 2390 | 0.010 |
Why?
|
Atrophy | 1 | 2007 | 1617 | 0.010 |
Why?
|
Registries | 2 | 1997 | 8402 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 2005 | 631 | 0.010 |
Why?
|
Ovariectomy | 1 | 2004 | 612 | 0.010 |
Why?
|
Young Adult | 1 | 2009 | 58143 | 0.010 |
Why?
|
Mohs Surgery | 1 | 2005 | 221 | 0.010 |
Why?
|
Aspartic Acid | 1 | 2004 | 576 | 0.010 |
Why?
|
Membrane Proteins | 3 | 2004 | 7825 | 0.010 |
Why?
|
Abdomen | 1 | 2008 | 1114 | 0.010 |
Why?
|
Genes, Tumor Suppressor | 2 | 1997 | 1058 | 0.010 |
Why?
|
Coloring Agents | 1 | 2004 | 560 | 0.010 |
Why?
|
Sex Factors | 1 | 1996 | 10491 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2004 | 750 | 0.010 |
Why?
|
Sulindac | 1 | 2001 | 28 | 0.010 |
Why?
|
Cell Proliferation | 2 | 2008 | 10382 | 0.010 |
Why?
|
Follow-Up Studies | 4 | 2009 | 39187 | 0.010 |
Why?
|
Endoscopy, Digestive System | 1 | 2004 | 352 | 0.010 |
Why?
|
Macrophage Activation | 1 | 2004 | 547 | 0.010 |
Why?
|
Cyclooxygenase 1 | 1 | 2001 | 97 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3272 | 0.010 |
Why?
|
Observer Variation | 1 | 2007 | 2596 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2004 | 1991 | 0.010 |
Why?
|
Glycine | 1 | 2004 | 662 | 0.010 |
Why?
|
Integrases | 1 | 2003 | 516 | 0.010 |
Why?
|
Chromosomes | 1 | 2004 | 576 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2007 | 1767 | 0.010 |
Why?
|
Immunoblotting | 1 | 2004 | 1650 | 0.010 |
Why?
|
Muscle Contraction | 1 | 2006 | 1200 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2008 | 2182 | 0.010 |
Why?
|
Colonoscopy | 1 | 2009 | 1386 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2004 | 608 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2004 | 1575 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6523 | 0.010 |
Why?
|
Furans | 1 | 2001 | 197 | 0.010 |
Why?
|
Adolescent | 5 | 2005 | 87297 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2001 | 747 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2004 | 2287 | 0.010 |
Why?
|
Estrogens | 1 | 2007 | 1520 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2008 | 3575 | 0.010 |
Why?
|
Genetic Engineering | 1 | 2006 | 932 | 0.010 |
Why?
|
Cysteine | 1 | 2004 | 888 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2006 | 1547 | 0.010 |
Why?
|
Gene Dosage | 1 | 2004 | 1219 | 0.010 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2002 | 364 | 0.010 |
Why?
|
RNA Interference | 1 | 2008 | 2843 | 0.010 |
Why?
|
Ubiquitin | 1 | 2004 | 833 | 0.010 |
Why?
|
Quinazolines | 1 | 2006 | 1356 | 0.010 |
Why?
|
Models, Biological | 2 | 2007 | 9453 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2007 | 20002 | 0.010 |
Why?
|
Age Factors | 1 | 1996 | 18372 | 0.010 |
Why?
|
Hepatectomy | 1 | 2002 | 561 | 0.010 |
Why?
|
Genetic Testing | 2 | 2005 | 3506 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2004 | 1774 | 0.010 |
Why?
|
Cattle | 1 | 2004 | 3845 | 0.010 |
Why?
|
Age of Onset | 1 | 2005 | 3297 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2006 | 1533 | 0.010 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2003 | 610 | 0.010 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 1999 | 350 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2004 | 1755 | 0.010 |
Why?
|
HeLa Cells | 1 | 2004 | 3096 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 4890 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2000 | 705 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2006 | 1186 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2004 | 1738 | 0.010 |
Why?
|
Gene Frequency | 1 | 2004 | 3588 | 0.010 |
Why?
|
beta 2-Microglobulin | 1 | 1998 | 321 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4569 | 0.010 |
Why?
|
Cohort Studies | 3 | 2004 | 41121 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2001 | 1790 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3785 | 0.010 |
Why?
|
Family | 2 | 2000 | 3188 | 0.010 |
Why?
|
Introns | 1 | 1999 | 974 | 0.010 |
Why?
|
Colostomy | 1 | 1997 | 104 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2004 | 2187 | 0.010 |
Why?
|
Viral Proteins | 1 | 2003 | 1802 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 6481 | 0.010 |
Why?
|
Nucleic Acid Conformation | 1 | 1999 | 896 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2005 | 2907 | 0.010 |
Why?
|
Morbidity | 1 | 2001 | 1764 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2004 | 2432 | 0.010 |
Why?
|
Forecasting | 1 | 2004 | 2928 | 0.010 |
Why?
|
Cell Membrane | 1 | 2005 | 3675 | 0.010 |
Why?
|
|